Methylfluorophosphonylcholine
Methylfluorophosphonylcholine (MFPC) is a chemical compound that belongs to the class of organophosphates. It is a synthetic compound that has been studied for its potential use in various applications, including as a neurotransmitter inhibitor and a potential nerve gas agent.
Chemical Structure
MFPC is composed of a methyl group (CH3), a fluorine atom (F), a phosphorus atom (P), and a choline group (C5H14NO). The phosphorus atom is bonded to the fluorine atom and the methyl group, forming a phosphonate group. The phosphonate group is then bonded to the choline group, forming the complete MFPC molecule.
Properties and Synthesis
MFPC is a colorless, odorless liquid at room temperature. It is highly reactive and can easily form bonds with other molecules. The synthesis of MFPC involves the reaction of dimethyl methylphosphonate with fluorine gas in the presence of a catalyst, followed by the addition of choline.
Applications
The primary application of MFPC is in the field of neuroscience. It acts as an inhibitor of the neurotransmitter acetylcholine, which plays a key role in the functioning of the nervous system. By inhibiting acetylcholine, MFPC can affect nerve signal transmission, making it a potential nerve gas agent.
However, the use of MFPC as a nerve gas is highly controversial and is subject to strict regulations under the Chemical Weapons Convention. Research is ongoing to explore other potential applications of MFPC, including its use in the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease.
Safety and Toxicity
Due to its potential use as a nerve gas, MFPC is classified as a highly toxic substance. Exposure to MFPC can cause a range of symptoms, including difficulty breathing, blurred vision, and loss of consciousness. Long-term exposure can lead to permanent damage to the nervous system.
See Also

This article is a neuroscience stub. You can help WikiMD by expanding it!
-
MFPCh Structure
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
